While progress has been made to influence the treatment landscape of Alzheimer’s disease, gaps to widespread therapeutic ...

A p-tau217 blood test predicted a 78% chance of cognitive decline within 10 years for symptom-free adults with very high ...

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk ...

Capt. Chesley 'Sully' Sullenberger, known for the Miracle on the Hudson, has announced an Alzheimer's diagnosis.

"Good candidates are individuals who are identified as having cognitive impairment distinct from normal aging via abnormal ...

A blood test may predict if apparently healthy older adults are likely to develop Alzheimer’s symptoms in the next five or 10 years, researchers ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

An experimental blood test could identify those at highest risk years before they start experiencing cognitive decline.

A future blood test may predict Alzheimer's risk a decade early—but experts warn it comes with big ethical questions.

An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering ...

Research presented this week at the Alzheimer’s Association International Conference in London suggests that the use of blood ...

Florida will require assisted living facilities to hold a special license to offer memory care services by 2027.